Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of argireline injection in China. Welcome to wholesale bulk high quality argireline injection for sale here from our factory. Good service and reasonable price are available.
Argireline (acetylhexapeptide-8), as a bioactive peptide with anti-wrinkle effects, has been widely used in the field of cosmetics. In recent years, with the development of precision medicine, the application of Argireline Injection in the field of medical aesthetics has gradually attracted attention. Precision medicine emphasizes formulating personalized treatment plans based on the individual differences of patients to enhance treatment outcomes and reduce risks. However, its application in precision medicine still faces many challenges, including the precision of injection techniques, the precision of patient selection, and the effectiveness of risk management and control, etc.
|
|
|
Argireline COA
 |
||
| Certificate of Analysis | ||
| Compound name | Argireline | |
| Grade | Pharmaceutical grade | |
| CAS No. | 616204-22-9 | |
| Quantity | 20g | |
| Packaging standard | PE bag+Al foil bag | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 202512090051 | |
| MFG | Dec 9th 2025 | |
| EXP | Dec 8th 2028 | |
| Structure |
|
|
| Item | Enterprise standard | Analysis result |
| Appearance | White or almost white powder | Conformed |
| Water content | ≤5.0% | 0.85% |
| Loss on drying | ≤1.0% | 0.21% |
| Heavy Metals | Pb≤0.5ppm | N.D. |
| As≤0.5ppm | N.D. | |
| Hg≤0.5ppm | N.D. | |
| Cd≤0.5ppm | N.D. | |
| Purity (HPLC) | ≥99.0% | 99.80% |
| Single impurity | <0.8% | 0.31% |
| Total microbial count | ≤750cfu/g | 84 |
| E. Coli | ≤2MPN/g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (by GC) | ≤5000ppm | 400ppm |
| Storage | Store in a sealed, dark, and dry place below-20°C | |
|
|
||
|
|
||
| Chemical Formula | C34H60N14O12S | |
| Exact Mass | 888.42 | |
| Molecular Weight | 889.00 | |
| m/z | 888.42(100.0%), 889.43(36.8%), 890.43(6.6%), 889.42(5.2%), 890.42(4.5%), 890.43(2.5%), 890.42(1.9%), 891.42(1.7%) | |
| Elemental Analysis | C,45.94; H,6.80; N,22.06; O,21.60; S,3.61 | |
Application of Precision Medicine
The precision of injection technology
Selection of Injection site
The injection site of this injection directly affects its anti-wrinkle effect.Precision medicine requires the selection of appropriate injection sites based on the distribution of the patient's facial muscles, the type and severity of wrinkles. For instance, for dynamic lines (such as crow's feet and frown lines), injections should be administered at the contracted areas of the expression muscles to block the release of neurotransmitters and reduce muscle contractions.
Control of Injection dose
The precise control of the injection dose is the key to its success. Excessive dosage may lead to side effects such as facial stiffness and unnatural expressions; If the dosage is too small, the expected anti-wrinkle effect may not be achieved. Precision medicine requires the formulation of personalized injection dosage plans based on factors such as the patient's age, weight, and skin condition.
The control of Injection depth
The precise control of the injection depth is crucial to the effectiveness and safety of this injection.Injecting too shallowly may cause the drug to spread to non-target areas, resulting in unnecessary side effects. If the injection is too deep, it may damage the deep tissues, causing adverse reactions such as pain and swelling. Precision medicine requires doctors to have rich experience and superb skills, and be able to accurately determine the depth of injection.
The accuracy of the patient's selection
Precise determination of indications:Not all patients are suitable for receiving this product. Precision medicine requires doctors to accurately determine whether a patient is suitable for treatment based on factors such as the patient's medical history, allergy history and skin condition. For instance, for pregnant women, lactating women and patients with severe skin diseases or immune system disorders, its use should be carefully considered or avoided.
Consideration of individual differences: Different patients have different skin types, wrinkle types and severity levels, and their responses to Argireline may also vary. Precision medicine requires doctors to fully consider the individual differences of patients and formulate personalized treatment plans. For instance, for patients with thin and sensitive skin, a lower concentration of Argireline injection should be selected, and the injection dose and frequency should be reduced.
The accuracy of therapeutic effect evaluation
Evaluation of short-term and long-term efficacy
The efficacy evaluation of Argireline Injection should include both short-term and long-term aspects. The short-term efficacy evaluation mainly focuses on the improvement degree of wrinkles after injection, the naturalness of facial expressions, etc. Long-term efficacy evaluation focuses on the recurrence of wrinkles, the overall condition of the skin, etc. Precision medicine requires the adoption of scientific and objective assessment methods, such as three-dimensional skin imaging technology and wrinkle depth measurement devices, to precisely evaluate the therapeutic effect.
Investigation of patient satisfaction
Patient satisfaction is one of the important indicators for evaluating the therapeutic effect of this injection. Precision medicine requires understanding patients' satisfaction with the treatment effect, as well as the adverse reactions and discomforts that occur during the treatment process, through methods such as questionnaires and face-to-face interviews. This helps doctors adjust the treatment plan in a timely manner, improving patients' satisfaction and treatment effect.
Risk management and control
Injection risk
Infection risk
Argireline Injection is an invasive operation and there is a risk of infection. Infection may cause local redness, swelling, pain, suppuration and other symptoms. In severe cases, it may even lead to systemic infection. To reduce the risk of infection, aseptic operating procedures should be strictly followed. Disposable syringes and needles should be used and the injection site should be thoroughly disinfected.
Bleeding and hematoma risk
During the injection process, blood vessels may be damaged, leading to bleeding and hematoma formation. To reduce the risk of bleeding and hematoma, one should be familiar with the distribution of facial blood vessels and avoid injections in areas with rich blood vessels. After injection, apply pressure to stop the bleeding and observe whether there is any bleeding or hematoma formation at the injection site.
Risk of nerve injury
This injection may damage the facial nerves, causing sequelae such as facial numbness and unnatural expressions.To reduce the risk of nerve injury, the injection site and depth should be accurately determined to avoid direct injection into the nerve trunk or nerve endings. During the injection process, the patient's reaction should be closely observed. If any abnormality occurs, the injection should be stopped immediately and corresponding measures should be taken.
Drug risks
Allergic reaction risk
Some patients may have allergic reactions to Argireline or other ingredients in the injection. Allergic reactions may cause symptoms such as rashes, itching, and breathing difficulties. In severe cases, they may even be life-threatening. To reduce the risk of allergic reactions, an allergy test should be conducted before injection to understand the patient's allergy history and prepare the necessary first aid equipment and medications.
Risk of drug side effects
This injection may cause some side effects, such as facial stiffness, unnatural expressions, local swelling, etc.These side effects are usually temporary, but in some cases they may last for a long time or affect the patient's quality of life. To reduce the risk of drug side effects, the injection dosage and frequency should be strictly controlled to avoid excessive injection. At the same time, patients should be fully informed of possible side effects and precautions so that they can take timely measures to relieve discomfort.
Operational risk
Doctor's technical risk: The efficacy and safety of this product are closely related to the technical level of the doctor.Unskilled doctors may lead to inaccurate injection sites, improper dosage control and other problems, thereby affecting the treatment effect and increasing the risk. To reduce the technical risks for doctors, the training and assessment of doctors should be strengthened to ensure that they have rich experience and superb skills. Meanwhile, a doctor qualification certification system should be established to strictly review and manage the qualifications of doctors.
Equipment and material risks: The quality of the equipment and materials used for this injection directly affects the efficacy and safety of the treatment. Low-quality equipment and materials may lead to problems such as inaccurate injection and drug leakage, thereby increasing the risk. To reduce the risks of equipment and materials, it is necessary to choose equipment and materials produced by regular manufacturers and carry out regular maintenance and inspection. At the same time, management systems for the procurement, acceptance, storage and use of equipment and materials should be established to ensure the quality and safety of equipment and materials.
Risk control strategy
Establish a sound risk management system: Medical institutions should establish a sound risk management system, clearly define the responsibilities and authorities of each department and personnel, and formulate risk control processes and emergency plans. Meanwhile, efforts should be made to enhance the publicity and training of the risk management system to ensure that all personnel are familiar with and abide by the relevant systems.
Strengthen patient education and communication: Before injection, the patient should be fully informed of the principle, effect, risks, precautions and other information of the injection solution to ensure that the patient fully understands and agrees to receive the treatment.Meanwhile, communication and interaction with patients should be strengthened to promptly understand their needs and feedback, so as to adjust the treatment plan and risk control measures in a timely manner.
Strengthen monitoring and evaluation: During and after the injection process, patients should be closely monitored and evaluated to promptly identify and handle any possible adverse reactions and complications. Meanwhile, the treatment effect should be evaluated and summarized regularly to continuously optimize the treatment plan and risk control measures.
Establish an adverse event reporting and handling mechanism: Medical institutions should establish a reporting and handling mechanism for adverse events and encourage medical staff to report adverse events related to this injection in a timely manner.Meanwhile, the analysis and handling of adverse events should be strengthened, experiences and lessons should be summarized, and effective measures should be taken to prevent the recurrence of similar events.
Case Analysis
Success cases
A certain patient chose to receive the injection treatment of this injection due to obvious dynamic wrinkles on the face. Based on the distribution of the patient's facial muscles, the type and severity of wrinkles, the doctor formulated a personalized treatment plan. During the injection process, the doctor strictly adheres to aseptic operation procedures, accurately determines the injection site and depth, and controls the injection dosage and frequency. After the injection, the dynamic wrinkles on the patient's face improved significantly, and no obvious adverse reactions occurred. After a period of follow-up, the patient expressed satisfaction with the therapeutic effect.
Failure cases
A certain patient is prone to believing false advertisements and chooses to receive injection treatment in an unregulated beauty institution. During the injection process, the doctor's lack of technical proficiency led to inaccurate injection sites and improper dosage control. After the injection, the patient experienced side effects such as facial stiffness and unnatural expressions, and local symptoms such as redness, swelling and pain occurred. The patient sought medical attention promptly and received treatment, but the side effects persisted for a relatively long time, affecting the patient's quality of life.
Argireline as a 'selective signal filter'
Argireline Injection (Acetyl Hexapeptide-8), as a representative substance of peptide active ingredients, is often mentioned in the field of skin care as having a "selective signal filter" function. This feature is not traditional electronic signal filtering, but specifically refers to its ability to accurately intervene in the neuromuscular signaling pathway, selectively block excessive neurotransmitter release, and improve skin dynamic wrinkle problems without affecting normal physiological functions.
The core definition of "selective signal filter": precise intervention rather than comprehensive blocking
Targeted: only acts on the key link of nerve muscle signal transmission
The release of neurotransmitters is a multi-step process: when nerve endings receive a "contraction" signal, calcium ions (Ca ² ⁺) enter the nerve endings, triggering synaptic vesicles to fuse with the cell membrane, ultimately releasing acetylcholine (ACh); After binding to receptors on the muscle cell membrane, ACh triggers muscle contraction. The target of Argireline is the synaptic vesicle associated membrane protein (VAMP), which is a key protein responsible for the fusion of synaptic vesicles with the cell membrane. It only exists at "signal release sites" such as neuromuscular junctions and neuromuscular junctions, and does not affect the contraction function of muscle cells themselves. It also does not act on the transmission pathways of other neurotransmitters such as dopamine and serotonin, achieving "selective signaling pathways".
Intensity selectivity: Prioritize the inhibition of "excessive signals" and preserve basic physiological signals
The generation of dynamic wrinkles on the skin (such as forehead wrinkles and crow's feet) is essentially due to long-term and excessive contraction of local muscles - that is, the continuous release of excessive ACh from nerve endings, leading to the muscles being in an "overactivated" state. Argireline, when combined with VAMP, slightly reduces the fusion efficiency between synaptic vesicles and cell membranes. It has minimal impact on the "basal ACh release" required to maintain daily facial expressions such as smiling and blinking, and does not cause facial stiffness; But for the "excessive ACh release" that triggers dynamic lines, it can significantly reduce the release efficiency, equivalent to "filtering out signals that exceed physiological needs" and reducing excessive muscle contraction from the source, which is the "selective signal strength".
Applications of Argireline Injection in Local Muscle Relaxation
Local Facial Muscle Relaxation: Alleviating Tension-Related Discomforts and Contour Stiffness
The face is the core application site of Argireline Injection in local muscle relaxation, mainly intervening in a series of problems caused by excessive tension of facial expression muscles. Facial expression muscles such as the frontalis, corrugator supercilii, orbicularis oculi and perioral muscles are prone to persistent contraction due to long-term emotional stress, frequent facial expressions and poor facial habits, which in turn cause muscle tension, facial tightness, contour stiffness and even accelerate the formation of dynamic wrinkles.
Precise injection of Argireline Injection into the tense muscle areas can reduce the frequency of excessive muscle contraction by regulating signal transmission between nerves and muscles, gradually relax the tense muscles, quickly relieve facial tightness and soreness, and improve facial contour stiffness caused by persistent muscle tension. For example, for the feeling of a furrowed brow caused by corrugator supercilii tension and periorbital muscle soreness due to excessive contraction of the orbicularis oculi, muscle relaxation can be achieved within 1-3 days after injection, leaving the face in a more relaxed state. Meanwhile, on the premise of not affecting normal facial expressions, it optimizes the softness of facial lines, avoids the aggravation of facial wrinkles due to long-term muscle tension, and balances muscle relaxation with facial condition management.
Neck Muscle Relaxation: Relieving Cervical Muscle Tension and Stiff Contours
As an important part connecting the head and trunk, the neck's muscles such as the sternocleidomastoid and platysma are prone to tension and strain due to long-term bowing, desk work and poor neck posture. This not only causes local neck soreness and stiffness, but may also lead to stiff neck lines and deepened neck wrinkles due to persistent platysma tension, affecting neck aesthetics and physical comfort. Argireline Injection can be administered via local microinjection to the tense neck muscles, acting primarily on the platysma and superficial neck muscles.
By relaxing the overcontracted neck muscles, it relieves neck soreness caused by muscle tension and mild pulling sensations during movement, and improves stiff neck lines due to platysma tension, keeping the neck muscles in a relaxed state, reducing dynamic neck wrinkles formed by skin pulling from muscle tension, and assisting in optimizing the smoothness of neck lines. This application is suitable for people prone to neck muscle tension such as long-term office workers and smartphone addicts, serving as an auxiliary method for daily neck muscle relaxation and neck anti-aging, and delivering dual value in alleviating physical discomfort and enhancing aesthetics.
Aesthetic Medicine Supporting Muscle Relaxation: Reducing Complications Caused by Postoperative Muscle Tension
In the field of aesthetic medicine, Argireline Injection is often used as a supporting preparation for various facial aesthetic procedures to exert local muscle relaxation effects after surgery and reduce complications caused by postoperative muscle tension. For example, after aesthetic procedures such as facial microneedling, mesotherapy, and laser skin rejuvenation, the skin may experience minor damage and redness, and facial muscles are prone to physiological tension due to postoperative discomfort.
Excessive muscle contraction may aggravate skin pulling, affect wound repair, and even lead to temporary deepening of skin wrinkles after surgery.At this time, microinjection of Argireline Injection into relevant facial areas can relax local muscle tension, reduce the pulling of damaged skin by muscle contraction, create a stable local environment for skin wound repair, accelerate postoperative skin recovery, and relieve facial tightness and soreness caused by postoperative muscle tension, thereby enhancing the experience and postoperative effects of aesthetic procedures. In addition, after facial contouring procedures such as dermal filling and thread lifting, combined use of this preparation to relax local muscles can reduce the pulling of filling materials and threads by muscle tension, improving the stability of contouring effects.
Application Advantages and Precautions for Local Muscle Relaxation
Argireline Injection has significant advantages in local muscle relaxation applications. First, it has strong targeting: precise injection can be performed according to the location of muscle tension, acting only on the target muscles without affecting surrounding normal muscle tissue. Second, it exerts a mild effect: it only inhibits excessive muscle contraction without causing muscle paralysis, preserving the normal physiological contractile function of muscles and avoiding problems such as facial stiffness and limited physical activity. Third, it is rapidly metabolized: as a polypeptide preparation, it can be naturally metabolized and decomposed by the human body with no residue and high safety.
Several precautions should be noted in application. Injection dosage and depth must be controlled by professional medical staff according to the degree of muscle tension to avoid excessively slow muscle contraction caused by overinjection. Meanwhile, excessive massage and hot compresses on the injection site should be avoided after injection to prevent drug diffusion from affecting the therapeutic effect. For problems such as severe muscle strain and neurogenic muscle tension, comprehensive intervention based on the etiology is required, and this preparation should not be relied on alone.
FAQ
Can Argireline be injected?
+
-
Can you inject Argireline? Yes, Argireline can be injected directly into the areas of the skin where wrinkles are most prominent, such as the forehead, around the eyes, and between the brows.
How long does Argireline last?
+
-
Effects can last up to 5 days
The effects of Argireline Amplified Peptide last around 5 days as the neurotransmitters reconnect the skin and the muscle. This means your results will improve over time with continued use as wrinkles and expression lines are preventatively diminished at an ongoing rate.
Hot Tags: argireline injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale